This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
British consumers have increasingly turned to communitypharmacies during the coronavirus pandemic, according to a new study. Research conducted by Ipsos Mori and commissioned by Johnson & Johnson Consumer Health EMEA surveyed between 6,000 people between 16 and 75. This rose to 68% in the 45-54 age bracket.
Our recent article, published in The International Journal of Drugs , presents the Australia-wide results. The use of opioid agonist treatment increased in non-communitypharmacy settings from early 2020. This increase was particularly evident in drug and alcohol outpatient clinics and prisons. Chidwick, K., Farrell, M.,
A new study by National Drug and Alcohol Research Centre (NDARC) researchers, led by PhD candidate Thomas Santo Jr, describes childhood trauma exposure among a sample of people prescribed opioids for CNCP. You can read the full paper published in Drug and Alcohol Dependence here.
ASHP’s full suite of drug information has been integrated into and made available through DrugBank, bringing together both company’s offerings to provide streamlined access to a broader range of high quality products.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content